Zer A - Search Results

1

Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy.

Rotem O, Zer A, Yosef L, Beery E, Goldvaser H, Gutkin A, Levin R, Dudnik E, Berger T, Feinmesser M, Levy-Barda A, Lahav M, Raanani P, Uziel O. Rotem O, et al. Among authors: zer a. Biomedicines. 2023 Jun 16;11(6):1730. doi: 10.3390/biomedicines11061730. Biomedicines. 2023. PMID: 37371825 Free PMC article.

2

Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC.

Zer A, Leighl N. Zer A, et al. Front Oncol. 2014 Nov 25;4:329. doi: 10.3389/fonc.2014.00329. eCollection 2014. Front Oncol. 2014. PMID: 25505733 Free PMC article. Review.

3

Reply to G. Spitzer and M.A. Socinski.

Zer A, Leighl NB. Zer A, et al. J Clin Oncol. 2015 Feb 10;33(5):525-6. doi: 10.1200/JCO.2014.58.5307. Epub 2015 Jan 12. J Clin Oncol. 2015. PMID: 25584009 No abstract available.

4

Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Sung M, Zer A, Walia P, Khoja L, Maganti M, Labbe C, Shepherd FA, Bradbury PA, Liu G, Leighl NB. Sung M, et al. Among authors: zer a. J Thorac Dis. 2020 May;12(5):2706-2712. doi: 10.21037/jtd.2020.04.30. J Thorac Dis. 2020. PMID: 32642178 Free PMC article. No abstract available.

5

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.

Zer A, Pond GR, Razak ARA, Tirona K, Gan HK, Chen EX, O'Sullivan B, Waldron J, Goldstein DP, Weinreb I, Hope AJ, Kim JJ, Chan KKW, Chan AK, Siu LL, Bernstein LJ. Zer A, et al. JAMA Otolaryngol Head Neck Surg. 2018 Jan 1;144(1):71-79. doi: 10.1001/jamaoto.2017.2235. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29167901 Free PMC article.

6

Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widens.

Zer A, Leighl NB. Zer A, et al. J Clin Oncol. 2014 Jun 20;32(18):1874-81. doi: 10.1200/JCO.2013.54.4270. Epub 2014 May 19. J Clin Oncol. 2014. PMID: 24841982 Review. No abstract available.

7

Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Zer A, Ding K, Lee SM, Goss GD, Seymour L, Ellis PM, Hackshaw A, Bradbury PA, Han L, O'Callaghan CJ, Tsao MS, Shepherd FA. Zer A, et al. J Thorac Oncol. 2016 Mar;11(3):312-23. doi: 10.1016/j.jtho.2015.11.010. Epub 2015 Dec 31. J Thorac Oncol. 2016. PMID: 26749487 Free article.

8

Evolution of Randomized Trials in Advanced/Metastatic Soft Tissue Sarcoma: End Point Selection, Surrogacy, and Quality of Reporting.

Zer A, Prince RM, Amir E, Abdul Razak A. Zer A, et al. J Clin Oncol. 2016 May 1;34(13):1469-75. doi: 10.1200/JCO.2015.64.3437. Epub 2016 Mar 7. J Clin Oncol. 2016. PMID: 26951308 Review.

9

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS).

Veitch Z, Zer A, Loong H, Salah S, Masood M, Gupta A, Bradbury PA, Hogg D, Wong A, Kandel R, Charames GS, Abdul Razak AR. Veitch Z, et al. Among authors: zer a. Sci Rep. 2019 May 14;9(1):7390. doi: 10.1038/s41598-019-43222-6. Sci Rep. 2019. PMID: 31089155 Free PMC article. Clinical Trial.

10

Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs.

Bugano DDG, Hess K, Jardim DLF, Zer A, Meric-Bernstam F, Siu LL, Razak ARA, Hong DS. Bugano DDG, et al. Among authors: zer a. Clin Cancer Res. 2017 Aug 1;23(15):4020-4026. doi: 10.1158/1078-0432.CCR-16-2354. Epub 2017 Apr 4. Clin Cancer Res. 2017. PMID: 28377482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters